Does MIANSERIN Cause Agranulocytosis? 102 Reports in FDA Database
Sharpen Your Memory & Focus Naturally
NeuroZoom — 35 clinically studied ingredients. No stimulants. Pure brain support.
According to the FDA Adverse Event Reporting System (FAERS), 102 reports of Agranulocytosis have been filed in association with MIANSERIN. This represents 4.0% of all adverse event reports for MIANSERIN.
102
Reports of Agranulocytosis with MIANSERIN
4.0%
of all MIANSERIN reports
18
Deaths
66
Hospitalizations
How Dangerous Is Agranulocytosis From MIANSERIN?
Of the 102 reports, 18 (17.6%) resulted in death, 66 (64.7%) required hospitalization, and 24 (23.5%) were considered life-threatening.
Is Agranulocytosis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for MIANSERIN. However, 102 reports have been filed with the FAERS database.
What Other Side Effects Does MIANSERIN Cause?
Toxicity to various agents (246)
Fall (201)
Coma (177)
Somnolence (163)
Off label use (141)
Drug abuse (132)
Confusional state (126)
Hyponatraemia (122)
Hypotension (113)
Poisoning deliberate (107)
What Other Drugs Cause Agranulocytosis?
CLOZAPINE (1,766)
CYCLOPHOSPHAMIDE (1,242)
RITUXIMAB (1,154)
SULFAMETHOXAZOLE\TRIMETHOPRIM (797)
PANTOPRAZOLE (599)
METHOTREXATE (550)
SODIUM (549)
EPIRUBICIN (491)
METAMIZOLE (438)
DOCETAXEL (436)
Which MIANSERIN Alternatives Have Lower Agranulocytosis Risk?
MIANSERIN vs MICAFUNGIN
MIANSERIN vs MICARDIS
MIANSERIN vs MICONAZOLE
MIANSERIN vs MIDAZOLAM
MIANSERIN vs MIDAZOLAM\MIDAZOLAM